Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting
- 8 April 2011
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 23 (8) , 980-987
Abstract
HIV-positive individuals who use injection drugs (IDU) may have lower rates of adherence to highly active antiretroviral therapy (ART). However, previous studies of factors associated with adherence to ART among IDU have been limited primarily to samples drawn from clinical settings and in areas with financial barriers to healthcare.We evaluated patterns of ART adherence and rates of plasma HIV RNA response among a Canadian cohort of community-recruited IDU. Using data from a community-recruited cohort of antiretroviral-naive HIV-infected IDU, we investigated ART adherence patterns based on prescription refill compliance and factors associated with time to plasma HIV-1 RNA suppression (p<0.001). These results demonstrate low rates of adherence to ART among a community-recruited cohort of IDU and reinforce the importance of adherence as the key determinant of successful virological response to antiretroviral therapy.Keywords
This publication has 38 references indexed in Scilit:
- “We fear the police, and the police fear us”: structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, UkraineAIDS Care, 2010
- Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug usersAddiction, 2010
- Uptake of and virological response to antiretroviral therapy among HIV‐infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort StudyHIV Medicine, 2009
- Poor Baseline Immune Function Predicts an Incomplete Immune Response to Combination Antiretroviral Treatment Despite Sustained Viral SuppressionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Impacto de la inmunodepresión basal y su grado de recuperación al año de terapia antirretroviral en sobrevida, complicaciones oportunistas y reacción de recuperación inmuneRevista médica de Chile, 2008
- Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapiesAIDS, 2007
- Clinical Care of the HIV-Infected Drug UserInfectious Disease Clinics of North America, 2007
- Substance Abuse and Psychiatric Disorders in HIV-Positive PatientsDrugs, 2006
- Determinants of survival following HIV-1 seroconversion after the introduction of HAARTThe Lancet, 2003
- Directly Observed Therapy for the Treatment of People with Human Immunodeficiency Virus Infection: A Work in ProgressClinical Infectious Diseases, 2002